Ransomware payments plummet, enterprises struggle with data retention costs, and DARPA explores growing massive bio structures in microgravity. Plus, T-Mobile retires a legacy device. Read more...

A quick look at recent stock market activity, including analyst ratings updates for Vera Therapeutics, RF Industries, and United Therapeutics, plus short interest fluctuations in MingZhu Logistics and XOMA Co. Read more...

Recent analyst reports show shifts in ratings for Bicycle Therapeutics, Pilgrim's Pride, NantHealth, and Provident Financial. Plus, a look at quantum computing stocks. Read more...

Capri explores selling Versace to Prada, potentially returning the brand to Italian ownership. Simultaneously, Capricor sees a boost with the priority review of Deramiocel. Read more...

Y Intercept Hong Kong Ltd has been actively investing in US markets, acquiring positions in Avidity Biosciences and 3M, and increasing its stake in Tripadvisor. Meanwhile, Hong Kong actor Vinci Wong declares bankruptcy. Read more...

King Felipe VI was awarded an honorary doctorate and stressed the importance of clear legal language and regulation of emerging technologies. Plus, political figures clash over justice and fiscal policy. Read more...

A summary of recent earnings call presentations and transcripts from CrowdStrike, Wave Life Sciences, Cryoport, ChromaDex, and Credo Technology, offering insights into their financial performance. Read more...

Recent scientific breakthroughs include AI-generated proteins, organic compounds on asteroid Bennu hinting at life, and the discovery of 19 new quasars. Read more...

Explore foreign investment strategies for 2025, the rise of private debt ETFs, and the growth of contract research organizations like Fortrea. Plus, new rules for digital payments. Read more...

Several institutional investors, including Bank of New York Mellon Corp and Illinois Municipal Retirement Fund, adjusted their holdings in various companies during the fourth quarter. New York Life Investment Management LLC and Los Angeles Capital Management LLC also made new investments. Read more...

This week's health news includes the benefits of sleep on blood sugar, risks of plastic containers, 3D-printed knee implants, and the passing of a blood donation hero. Read more...

A roundup of recent stock market news, including analyst upgrades for Sabre, an analysis of Wingstop's potential rebound, and a financial comparison of PACCAR and Volkswagen. Read more...

From outrageous baggage fees to a potentially game-changing biotech stock and HPE layoffs, the business world keeps serving up surprises. Read on for the latest. Read more...

Stifel Nicolaus has recently initiated coverage on several companies, including Martin Marietta Materials, Sionna Therapeutics, and Vulcan Materials, issuing "buy" ratings and setting price targets. Lightspeed Commerce Inc. receives a "Moderate Buy" consensus. Read more...

Several institutional investors, including Principal Financial, Rhumbline Advisers, and Private Trust Co. NA, adjusted their stock holdings in Q4, impacting companies like Petco, Legend Biotech, and Centene Co. Analysts also updated earnings estimates for WESCO International and PEDEVCO. Read more...

Scientists at Colossal Biosciences have created a "woolly mouse" as a first step in their ambitious plan to bring back the woolly mammoth. The project aims to introduce mammoth traits into Asian elephants. Read more...

A recap of today's political news, including a Senate hearing on wildfires, a White House press briefing, and developments concerning the Obama Presidential Library. Read more...

Mutual of America Capital Management LLC has adjusted its holdings in several biotech and tech companies, including Cytokinetics, Lumentum Holdings, and Bio-Techne Co., according to recent SEC filings. StockNews.com also upgraded Acacia Research. Read more...

Unlock your business's potential with digital solutions, SEO strategies, and targeted marketing. Discover essential tools and tips for growth and success. Read more...

William Blair reaffirmed ratings for AvePoint and Biodesix, reiterated a "market perform" for Fortrea, and issued Q1 earnings forecast for Rocket Pharmaceuticals. Read more...